| Sym013 (Pan-HER) in Patients With Advanced Epithelial Malignancies (NCT02906670) | Symphogen A/S | 2016-11-01 |
| Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) (NCT02927080) | Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 2016-11-01 |
| Evaluation of Efficacy and Safety of SPARC1401 in Acute Low Back Pain (NCT02887534) | Sun Pharma Advanced Research Company Limited | 2016-11-01 |
| uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer (NCT02960724) | Rigshospitalet, Denmark | 2016-11-01 |
| Does a Rescue Course of Betamethasone in Pregnant Women With PPROM Decrease Neonatal Morbidity? (NCT02939742) | The University of Texas Medical Branch, Galveston | 2016-11-01 |
| Evaluation of the Efficacy and Safety of LevoCept (NCT02882191) | Sebela Women's Health Inc. | 2016-11-01 |
| Vinorelbine for Recurrent ALCL-2017 (NCT03443128) | Children's Cancer Group, China | 2016-11-01 |
| Nivolumab in Relapsed Pediatric Solid Tumors (NCT02901145) | Hadassah Medical Organization | 2016-11-01 |
| Oral Navelbine and Cisplatin Followed by Metronomic Oral Navelbine in Non-Small Cell Lung Cancer (NCT02985203) | Guangdong Association of Clinical Trials | 2016-11-01 |
| Self-management of Sedative Therapy by Ventilated Patients (NCT02819141) | Mayo Clinic | 2016-11-01 |
| Gefitinib Combined With Chemotherapy or Antiangiogensis in Patients With Bim Deletion or Low EGFR Mutation Abundance (NCT02930954) | Caicun Zhou | 2016-11-01 |
| A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma Subjects (NCT03265106) | Shenzhen BinDeBio Ltd. | 2016-11-01 |
| Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents (NCT02964377) | Craig McDonald, MD | 2016-11-01 |
| Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis (NCT02950922) | Dermavant Sciences GmbH | 2016-11-01 |
| Efficacy of Low Dose, SubQ Interleukin-2 (IL-2) to Expand Endogenous Regulatory T-Cells in Liver Transplant Recipients (NCT02739412) | Beth Israel Deaconess Medical Center | 2016-11-01 |
| NM-IL-12 (rHuIL-12) In Relapsed/Refractory Diffuse Large B- Cell Lymphoma (DLBCL) Undergoing Salvage Chemotherapy (NCT02544724) | Neumedicines Inc. | 2016-11-01 |
| Feasibility Trial Testing the Bionic Pancreas With ZP4207 (NCT02971228) | Zealand Pharma | 2016-11-01 |
| Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer (NCT02784288) | University of Michigan Rogel Cancer Center | 2016-10-31 |
| Pharmacodynamics, Pharmacokinetics and Safety of Two Doses of CHF6001 DPI in Subjects With Moderate, Severe COPD (NCT03004417) | Chiesi Farmaceutici S.p.A. | 2016-10-31 |
| A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors (NCT02923349) | Incyte Biosciences International Sàrl | 2016-10-31 |
| Study to Evaluate the Efficacy and Safety of BIIB074 in Neuropathic Pain From Lumbosacral Radiculopathy (NCT02935608) | Biogen | 2016-10-31 |
| Safety and Efficacy Study of SOM230 s.c. in Cluster Headache (NCT02619617) | Novartis Pharmaceuticals | 2016-10-31 |
| TAS-OX for Refractory Metastatic Colon Cancer (NCT02848079) | Yale University | 2016-10-31 |
| Anti-EGFR-immunoliposomes Loaded With Doxorubicin in Patients With Advanced Triple Negative EGFR Positive Breast Cancer (NCT02833766) | Swiss Cancer Institute | 2016-10-28 |
| Study of Local Administration of DepoTXA for Reduced Postsurgical Bleeding in Subjects Undergoing TKA (NCT02922582) | Pacira Pharmaceuticals, Inc | 2016-10-28 |
| An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris (NCT02720627) | Cassiopea SpA | 2016-10-28 |
| Bosutinib in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase After Frontline TKI Failure (NCT02906696) | M.D. Anderson Cancer Center | 2016-10-28 |
| FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer (NCT02890355) | National Cancer Institute (NCI) | 2016-10-27 |
| BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia (NCT02933320) | Cancer Research UK | 2016-10-27 |
| The PertADO Geneva Trial (NCT02946190) | Siegrist Claire-Anne | 2016-10-27 |
| Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis. (NCT02840721) | Telavant, Inc. | 2016-10-26 |
| Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms (NCT02790034) | Newron Pharmaceuticals SPA | 2016-10-26 |
| Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH) (NCT02854605) | Gilead Sciences | 2016-10-26 |
| Pivotal Phase 2b/3 ALVAC/Bivalent gp120/MF59 HIV Vaccine Prevention Safety and Efficacy Study in South Africa (NCT02968849) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-10-26 |
| A Study of Pembrolizumab in Patients With Neuroendocrine Tumors (NCT02939651) | Fox Chase Cancer Center | 2016-10-26 |
| Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma (NCT02945800) | H. Lee Moffitt Cancer Center and Research Institute | 2016-10-25 |
| Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine Regimens in Adult Participants Hospitalized With Respiratory Syncytial Virus (NCT02935673) | Janssen Research & Development, LLC | 2016-10-25 |
| A Study to Evaluate ABT-494 (Upadacitinib) in Adults With Moderate to Severe Atopic Dermatitis (NCT02925117) | AbbVie | 2016-10-25 |
| A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma (NCT03070964) | PharmaMar | 2016-10-25 |
| Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor (NCT02738866) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-10-25 |
| Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With NASH (NCT02913105) | Novartis Pharmaceuticals | 2016-10-24 |
| Trial of the Reactogenicity, Safety and Immunogenicity of the Flu-M Vaccine Manufactured by FSUE SPbSRIVS FMBA (NCT05297994) | St. Petersburg Research Institute of Vaccines and Sera | 2016-10-24 |
| Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH) (NCT02787304) | Mirum Pharmaceuticals, Inc. | 2016-10-24 |
| A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL) (NCT02857426) | Bristol-Myers Squibb | 2016-10-21 |
| A Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid Tumors (NCT02829723) | Novartis Pharmaceuticals | 2016-10-21 |
| Safety Study of Zimura in Combination With Anti-VEGF Therapy in Patients With Neovascular AMD (NCT05571267) | IVERIC bio, Inc. | 2016-10-20 |
| Breast Cancer With Intraoperative Radiotherapy Followed by Hypofractionated External Beam Radiotherapy (NCT05498311) | Institut Català d'Oncologia | 2016-10-20 |
| Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor Malignancies (NCT02913131) | Rahul Aggarwal | 2016-10-20 |
| Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours (NCT02855203) | Peter MacCallum Cancer Centre, Australia | 2016-10-20 |
| Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE) (NCT02847598) | Biogen | 2016-10-20 |
| Preoperative Administration of Olaparib With Cisplatin or With Durvalumab or Alone or no Tratment in Patients Who Are Candidates for Surgery of Carcinoma of the Head and Neck. (NCT02882308) | Hellenic Cooperative Oncology Group | 2016-10-20 |
| Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder (NCT02871427) | Axovant Sciences Ltd. | 2016-10-20 |
| Exploratory Trial of TAS-303 in Female Patients With Stress Urinary Incontinence (NCT02906683) | Taiho Pharmaceutical Co., Ltd. | 2016-10-20 |
| A Dose Response Study of E6011 in Participants With Rheumatoid Arthritis Inadequately Responding to Methotrexate (NCT02960438) | Eisai Co., Ltd. | 2016-10-20 |
| A Clinica Study of Pyrotinib in Patients of Advanced Non-Small Cell Lung Cancer With HER2 Mutation (NCT02834936) | Jiangsu HengRui Medicine Co., Ltd. | 2016-10-20 |
| A Phase 2 Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment With Elamipretide in Patients Hospitalized With Congestion Due to Heart Failure (NCT02914665) | Stealth BioTherapeutics Inc. | 2016-10-20 |
| A Phase II Trial If Nivolumab, Lenalidomide and Dexamethasone in High Risk Smoldering Myeloma (NCT02903381) | Dana-Farber Cancer Institute | 2016-10-20 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants (NCT02908685) | Hoffmann-La Roche | 2016-10-19 |
| Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy (NCT02903368) | Dana-Farber Cancer Institute | 2016-10-19 |
| A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection (NCT02765802) | Eiger BioPharmaceuticals | 2016-10-19 |
| Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome (NCT02843659) | Bristol-Myers Squibb | 2016-10-18 |
| Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH) (NCT02912260) | Madrigal Pharmaceuticals, Inc. | 2016-10-18 |
| Study Of Single-dose Cyclophosphamide +Pembrolizumab In Patients With Metastatic Triple Negative Breast Cancer (NCT02768701) | UNC Lineberger Comprehensive Cancer Center | 2016-10-18 |
| Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) (NCT02858492) | GlaxoSmithKline | 2016-10-17 |
| Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease (NCT02847650) | Pfizer | 2016-10-17 |
| Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis (NCT02817958) | UNICANCER | 2016-10-17 |
| A Challenge Study to Assess the Safety, Immunogenicity and Efficacy of a Malaria Vaccine Candidate (NCT02927145) | University of Oxford | 2016-10-17 |
| Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer (NCT02770391) | Case Comprehensive Cancer Center | 2016-10-17 |
| Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension (NCT02960204) | Histogen | 2016-10-17 |
| Effects of Glucagon Like Peptide 1 (GLP-1) Analogues on Fluid Intake (NCT03141632) | University Hospital, Basel, Switzerland | 2016-10-17 |
| Carfilzomib and TGR-1202 in Treatment of R/R Lymphoma (NCT02867618) | Columbia University | 2016-10-16 |
| Effect of Secukinumab in the Treatment of Psoriatic Arthritis (NCT02854163) | University of Liverpool | 2016-10-15 |
| A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma (NCT02773030) | Celgene | 2016-10-14 |
| Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV∆G-ZEBOV-GP Vaccine) (NCT02788227) | National Institutes of Health Clinical Center (CC) | 2016-10-14 |
| Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients (NCT02935595) | The University of Texas Health Science Center, Houston | 2016-10-14 |
| Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB (NCT04520022) | Gangnam Severance Hospital | 2016-10-13 |
| An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy (NCT02907619) | Pfizer | 2016-10-13 |
| Fat Malabsorption in Chronic Pancreatitis (NCT02849704) | Children's Hospital of Philadelphia | 2016-10-13 |
| Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44) (NCT02676349) | Institut de Cancérologie de Lorraine | 2016-10-13 |
| A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency (NCT02873975) | Dana-Farber Cancer Institute | 2016-10-12 |
| Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal Cancer (NCT02870920) | Canadian Cancer Trials Group | 2016-10-12 |
| AZD1419 Ph2a Study (NCT02898662) | AstraZeneca | 2016-10-12 |
| Study of Parkinson's Early Stage With Deferiprone (NCT02728843) | ApoPharma | 2016-10-12 |
| Safety and Efficacy of D-PLEX in the Prevention of Sternal Infection Post Cardiac Surgery. (NCT02731573) | PolyPid Ltd. | 2016-10-12 |
| Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving Chemotherapy (NCT02732015) | M.D. Anderson Cancer Center | 2016-10-12 |
| Autologous Lung Stem Cell Transplantation in Patients With Interstitial Lung Diseases (NCT02796781) | Shanghai East Hospital | 2016-10-12 |
| A Study of MHAA4549A as Monotherapy for Acute Uncomplicated Seasonal Influenza A in Otherwise Healthy Adults (NCT02623322) | Genentech, Inc. | 2016-10-12 |
| Efficacy and Safety of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis Due to T.b. Gambiense (NCT03087955) | Drugs for Neglected Diseases | 2016-10-11 |
| High-Flow Oxygen for Dyspnea in Hospitalized Cancer Patients (NCT02932332) | M.D. Anderson Cancer Center | 2016-10-11 |
| Trial of Bortezomib, Cytarabine, and Dexamethasone in Mantle Cell Lymphoma (NCT02840539) | Seoul National University Hospital | 2016-10-11 |
| A Study of PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer (NCT02901483) | PharmaEngine | 2016-10-11 |
| Pembrolizumab in Metastatic Anal Cancer (NCT02919969) | Dana-Farber Cancer Institute | 2016-10-11 |
| Web-based Intervention to Improve Executive Functioning in Teens With Epilepsy (Epilepsy Journey) (NCT02925663) | Children's Hospital Medical Center, Cincinnati | 2016-10-10 |
| Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases (NCT02913417) | David Minor, MD | 2016-10-10 |
| Hypovitaminosis D in Neurocritical Patients (NCT02881957) | University of Utah | 2016-10-10 |
| GLP1-imaging Before and After Bariatric Surgery (NCT03182231) | Radboud University Medical Center | 2016-10-07 |
| TGR-1202 and Ibrutinib in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (NCT02874404) | University of Nebraska | 2016-10-07 |
| Project 3, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in People With Current Affective Disorders (NCT02232737) | Brown University | 2016-10-07 |
| Impact of GHRH on Sleep Promotion and Endocrine Regulation in Service Members Who Sustained a Traumatic Brain Injury and Have Current Insomnia (NCT02931474) | National Institute of Nursing Research (NINR) | 2016-10-06 |
| Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects (NCT02798406) | DNAtrix, Inc. | 2016-10-06 |